Glycine

Glycine

SCHEMBL8303383

C=C(NC(C)=O)C(=O)O.NCC(=O)O

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADORA1ADORA2AADORA2BADORA3PDE3APDE3BPDE4APDE4BPDE4CPDE4D

The experimentally established mechanism targets of Glycine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
GLRA1 P23415 1/20 0.43
SLC6A9 P48067 1/20 0.43
OR51E2 Q9H255 1/20 0.43
CRBN Q96SW2 1/20 0.37
TAS2R38 P59533 1/20 0.34
KDM4E B2RXH2 1/20 0.32
KDM6B O15054 1/20 0.32
KDM5C P41229 1/20 0.32
EGLN1 Q9GZT9 1/20 0.32
PHF8 Q9UPP1 1/20 0.32
KDM2A Q9Y2K7 1/20 0.32
ALOX15 P16050 1/20 0.30
HSD17B10 Q99714 1/20 0.30
GABRR1 P24046 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL346338 0.86
Methyl Alcohol SCHEMBL8740635 0.84 CRBN (0.39) CRBNTAS2R38KDM4E
SCHEMBL15080651 0.77 CRBN (0.35) CRBNTAS2R38
Acrylamide SCHEMBL28097172 0.77 ALDH1A1 (0.46) CRBNTAS2R38ALOX15HSD17B10
Methacrylic Acid SCHEMBL3621684 0.76 GLRA1 (0.59) GLRA1SLC6A9OR51E2KDM4EKDM6B
Methacrylic Acid SCHEMBL8620266 0.76 GLRA1 (0.59) GLRA1SLC6A9OR51E2KDM4EKDM6B
SCHEMBL11304412 0.75 GLRA1 (0.36) GLRA1SLC6A9OR51E2
Glycine SCHEMBL1947837 0.71 GLRA1 (0.59) GLRA1SLC6A9OR51E2CRBNKDM4E
Glycine SCHEMBL10795794 0.70 GLRA1 (0.67) GLRA1SLC6A9OR51E2KDM4EKDM6B
Pyruvate SCHEMBL8404862 0.70 GLRA1 (0.67) GLRA1SLC6A9OR51E2KDM4EKDM6B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0581250-B1 Process for biotechnical preparation of L-thienylalanines in enantiomere pure form from 2-hydroxy-3-thienyl-acrylic acids and their use HOECHST AG (DE) 1999-03-03 EP disclosed
EP-0581250-A2 Process for biotechnical preparation of L-thienylalanines in enantiomere pure form from 2-hydroxy-3-thienyl-acrylic acids and their use HOECHST AKTIENGESELLSCHAFT (DE) 1994-02-02 EP disclosed